Management of recurrent cervical cancer with peritoneal carcinomatosis with HIPEC

•Recurrent cervical cancer with peritoneal carcinomatosis is rare.•Presenting two cases of recurrent cervical cancer with peritoneal carcinomatosis.•HIPEC used in recurrent cervical cancer cases with peritoneal carcinomatosis. Cervical cancer is the fourth most common malignancy in women in the worl...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology reports 2022-02, Vol.39, p.100909, Article 100909
Main Authors: Lantsman, Taliya, Lepe, Marcos, Garrett, Leslie, Goodman, Martin, Shea, Meghan
Format: Article
Language:English
Subjects:
Case Report
HIPEC
Peritoneal carcinomatosis
Recurrent cervical cancer
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Recurrent cervical cancer with peritoneal carcinomatosis is rare.•Presenting two cases of recurrent cervical cancer with peritoneal carcinomatosis.•HIPEC used in recurrent cervical cancer cases with peritoneal carcinomatosis. Cervical cancer is the fourth most common malignancy in women in the world; however, a substantial portion of these malignancies are declining with increasingly sophisticated screening. Unfortunately, recurrent cervical cancer has a dismal prognosis and its management continues to be a growing area of research. While the foundation oftreatment remains platinum-basedchemotherapies, new techniques such as HIPEC have been evaluated. We present two patients with recurrent cervical adenocarcinoma with peritoneal carcinomatosis who were treated with HIPEC during de-bulking surgery with substantial disease-free survival. One of our patientshad 15 months of disease-free survival before developing biliary metastases and the other remains disease free for over 24 months.
ISSN:2352-5789
2352-5789
DOI:10.1016/j.gore.2021.100909